Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K T Chong

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Non-peptidic HIV protease inhibitors: C2-symmetry-based design of bis-sulfonamide dihydropyronesM N Janakiraman, K D Watenpaugh, P K Tomich, et al.
Pathogens (Basel, Switzerland)|February 26, 2025
Age-Dependent Variations in the Distribution of <i>Aeromonas</i> Species in Human Enteric InfectionsAdhiraj Singh, Fang Liu, Christopher Yuwono, et al.
Journal of Medicinal Chemistry|September 1, 1995
Structure-based design of novel HIV protease inhibitors: carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitorsS Thaisrivongs, K D Watenpaugh, W J Howe, et al.
Journal of Medicinal Chemistry|January 21, 1994
Evaluation of a vitamin-cloaking strategy for oligopeptide therapeutics: biotinylated HIV-1 protease inhibitorsI Islam, K Y Ng, K T Chong, et al.
Journal of Medicinal Chemistry|October 27, 1995
Structure-based design of nonpeptidic HIV protease inhibitors from a cyclooctylpyranone lead structureK R Romines, K D Watenpaugh, W J Howe, et al.
Journal of Medicinal Chemistry|June 7, 1996
Structure-based design of novel HIV protease inhibitors: sulfonamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent non-peptidic inhibitorsS Thaisrivongs, M N Janakiraman, K T Chong, et al.
Journal of Medicinal Chemistry|September 27, 1996
Cycloalkylpyranones and cycloalkyldihydropyrones as HIV protease inhibitors: exploring the impact of ring size on structure-activity relationshipsK R Romines, J K Morris, W J Howe, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
Antiviral activity of the dihydropyrone PNU-140690, a new nonpeptidic human immunodeficiency virus protease inhibitorS M Poppe, D E Slade, K T Chong, et al.
Journal of Medicinal Chemistry|August 28, 1998
Tipranavir (PNU-140690): a potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide classS R Turner, J W Strohbach, R A Tommasi, et al.
Journal of Medicinal Chemistry|November 8, 1996
Structure-based design of HIV protease inhibitors: 5,6-dihydro-4-hydroxy-2-pyrones as effective, nonpeptidic inhibitorsS Thaisrivongs, D L Romero, R A Tommasi, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Non-peptidic HIV protease inhibitors: C2-symmetry-based design of bis-sulfonamide dihydropyronesM N Janakiraman, K D Watenpaugh, P K Tomich, et al.
Pathogens (Basel, Switzerland)|February 26, 2025
Age-Dependent Variations in the Distribution of <i>Aeromonas</i> Species in Human Enteric InfectionsAdhiraj Singh, Fang Liu, Christopher Yuwono, et al.
Journal of Medicinal Chemistry|September 1, 1995
Structure-based design of novel HIV protease inhibitors: carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitorsS Thaisrivongs, K D Watenpaugh, W J Howe, et al.
Journal of Medicinal Chemistry|January 21, 1994
Evaluation of a vitamin-cloaking strategy for oligopeptide therapeutics: biotinylated HIV-1 protease inhibitorsI Islam, K Y Ng, K T Chong, et al.
Journal of Medicinal Chemistry|October 27, 1995
Structure-based design of nonpeptidic HIV protease inhibitors from a cyclooctylpyranone lead structureK R Romines, K D Watenpaugh, W J Howe, et al.
Journal of Medicinal Chemistry|June 7, 1996
Structure-based design of novel HIV protease inhibitors: sulfonamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent non-peptidic inhibitorsS Thaisrivongs, M N Janakiraman, K T Chong, et al.
Journal of Medicinal Chemistry|September 27, 1996
Cycloalkylpyranones and cycloalkyldihydropyrones as HIV protease inhibitors: exploring the impact of ring size on structure-activity relationshipsK R Romines, J K Morris, W J Howe, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
Antiviral activity of the dihydropyrone PNU-140690, a new nonpeptidic human immunodeficiency virus protease inhibitorS M Poppe, D E Slade, K T Chong, et al.
Journal of Medicinal Chemistry|August 28, 1998
Tipranavir (PNU-140690): a potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide classS R Turner, J W Strohbach, R A Tommasi, et al.
Journal of Medicinal Chemistry|November 8, 1996
Structure-based design of HIV protease inhibitors: 5,6-dihydro-4-hydroxy-2-pyrones as effective, nonpeptidic inhibitorsS Thaisrivongs, D L Romero, R A Tommasi, et al.
Pageof 5